Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Murphy

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Drug and Alcohol Dependence|August 11, 2020
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trialAli Jalali, Danielle A Ryan, Philip J Jeng, et al.
Drug and Alcohol Dependence|October 29, 2022
Evaluating equity in community-based naloxone access among racial/ethnic groups in MassachusettsShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
Addiction (Abingdon, England)|February 28, 2017
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorderSean M Murphy, Daniel Polsky, Joshua D Lee, et al.
Health Services Research|July 6, 2023
Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019Avik Chatterjee, Shapei Yan, Audrey Lambert, et al.
Journal of the American Pharmacists Association : Japha|April 11, 2024
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United StatesChristina E Freibott, Ali Jalali, Sean M Murphy, et al.
Journal of Substance Abuse Treatment|January 23, 2021
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)Elizabeth A Evans, Thomas J Stopka, Ekaterina Pivovarova, et al.
Drug and Alcohol Dependence Reports|November 7, 2022
The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York CityJake R Morgan, Christina E Freibott, Ali Jalali, et al.
The International Journal on Drug Policy|November 22, 2024
Increases in employment over six months following Khanya: A secondary analysis of a pilot randomized controlled trial of a peer-delivered behavioral intervention for substance use and HIV medication adherence in Cape Town, South AfricaJennifer M Belus, Kristen S Regenauer, Thanh Lu, et al.
Addiction (Abingdon, England)|August 28, 2023
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USAXiao Zang, Alexander Y Walley, Avik Chatterjee, et al.
Addiction (Abingdon, England)|October 28, 2022
Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17Sungwoo Lim, Teena Cherian, Monica Katyal, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Drug and Alcohol Dependence|August 11, 2020
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trialAli Jalali, Danielle A Ryan, Philip J Jeng, et al.
Drug and Alcohol Dependence|October 29, 2022
Evaluating equity in community-based naloxone access among racial/ethnic groups in MassachusettsShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
Addiction (Abingdon, England)|February 28, 2017
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorderSean M Murphy, Daniel Polsky, Joshua D Lee, et al.
Health Services Research|July 6, 2023
Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019Avik Chatterjee, Shapei Yan, Audrey Lambert, et al.
Journal of the American Pharmacists Association : Japha|April 11, 2024
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United StatesChristina E Freibott, Ali Jalali, Sean M Murphy, et al.
Journal of Substance Abuse Treatment|January 23, 2021
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)Elizabeth A Evans, Thomas J Stopka, Ekaterina Pivovarova, et al.
Drug and Alcohol Dependence Reports|November 7, 2022
The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York CityJake R Morgan, Christina E Freibott, Ali Jalali, et al.
The International Journal on Drug Policy|November 22, 2024
Increases in employment over six months following Khanya: A secondary analysis of a pilot randomized controlled trial of a peer-delivered behavioral intervention for substance use and HIV medication adherence in Cape Town, South AfricaJennifer M Belus, Kristen S Regenauer, Thanh Lu, et al.
Addiction (Abingdon, England)|August 28, 2023
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USAXiao Zang, Alexander Y Walley, Avik Chatterjee, et al.
Addiction (Abingdon, England)|October 28, 2022
Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17Sungwoo Lim, Teena Cherian, Monica Katyal, et al.
Pageof 18